Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153613 | SCV000203159 | uncertain significance | not provided | 2014-04-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003231346 | SCV000829764 | uncertain significance | Sotos syndrome | 2021-08-30 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with threonine at codon 2691 of the NSD1 protein (p.Ala2691Thr). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and threonine. This variant is present in population databases (rs201823140, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with NSD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 167395). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV003231346 | SCV002054911 | uncertain significance | Sotos syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV003231346 | SCV002792373 | uncertain significance | Sotos syndrome | 2022-02-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000153613 | SCV004702658 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | NSD1: BS2 |